Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEX-CRH test as a predictor of treatment effect in depression
2010-022673-33Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Jul 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of citalopram, dexamethasone and corticotrophin-releasing hormone in major depressive disorder (MDD), sponsored by Karolinska University Hospital. Primary endpoints: Change in Montgomery-Asberg Depression Rating Scale total score and Change in Karolinska Exhaustion Disorder Rating Scale total score. Started Jul 2011; status: active.
02
Drugs
citalopramdexamethasonecorticotrophin-releasing hormone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2010-022673-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022673-33.